INTRAPERITONEAL (IP) RADIOIMMUNOTHERAPY WITH I-131-LABELLED AND Y-90-LABELED MONOCLONAL-ANTIBODIES

被引：0
|
作者：
STEWART, JSW [1 ]
HIRD, V [1 ]
EPENETOS, AA [1 ]
机构：
[1] HAMMERSMITH HOSP,IMPERIAL CANC RES FUND GRP,LONDON W12 0HS,ENGLAND
来源：
BRITISH JOURNAL OF CANCER | 1989年 / 59卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：313 / 313
页数：1
相关论文
共 50 条
  • [1] INTRAPERITONEAL I-131-LABELLED AND Y-90-LABELED MONOCLONAL-ANTIBODIES FOR OVARIAN-CANCER - PHARMACOKINETICS AND NORMAL TISSUE DOSIMETRY
    STEWART, JSW
    HIRD, V
    SNOOK, D
    SULLIVAN, M
    MYERS, MJ
    EPENETOS, AA
    INTERNATIONAL JOURNAL OF CANCER, 1988, : 71 - 76
  • [2] Y-90-LABELED MONOCLONAL-ANTIBODIES FOR CANCER-THERAPY
    WASHBURN, LC
    SUN, TT
    CROOK, JE
    BYRD, BL
    CARLTON, JE
    STEPLEWSKI, ZS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1985, 189 (APR-): : 47 - NUCL
  • [3] RADIOIMMUNOTHERAPY OF HUMAN COLONIC-CANCER XENOGRAFTS WITH Y-90-LABELED MONOCLONAL-ANTIBODIES TO CARCINOEMBRYONIC ANTIGEN
    SHARKEY, RM
    KALTOVICH, FA
    SHIH, LB
    FAND, I
    GOVELITZ, G
    GOLDENBERG, DM
    CANCER RESEARCH, 1988, 48 (11) : 3270 - 3275
  • [4] INTRAPERITONEAL RADIOIMMUNOTHERAPY FOR OVARIAN-CANCER - RADIOPHARMACOKINETICS, TOXICITY AND EFFICACY OF I-131 LABELED MONOCLONAL-ANTIBODIES
    STEWART, JSW
    HIRD, V
    LAMBERT, HE
    EPENETOS, AA
    BRITISH JOURNAL OF CANCER, 1988, 58 (04) : 519 - 519
  • [5] INTRAPERITONEAL RADIOIMMUNOTHERAPY FOR OVARIAN-CANCER - PHARMACOKINETICS, TOXICITY, AND EFFICACY OF I-131 LABELED MONOCLONAL-ANTIBODIES
    STEWART, JSW
    HIRD, V
    SNOOK, D
    SULLIVAN, M
    HOOKER, G
    COURTENAYLUCK, N
    SIVOLAPENKO, G
    GRIFFITHS, M
    MYERS, MJ
    LAMBERT, HE
    MUNRO, AJ
    EPENETOS, AA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 16 (02): : 405 - 413
  • [6] MINIMAL RESIDUAL DISEASE - A TARGET FOR RADIOIMMUNOTHERAPY WITH I-131 OR Y-90 LABELED MONOCLONAL-ANTIBODIES - SOME DOSIMETRIC CONSIDERATIONS
    HERBOLD, G
    SAUTTERBIHL, ML
    DORR, U
    BIHL, H
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1992, 19 (08): : 610 - 610
  • [7] Radioimmunotherapy of glioblastoma by using I-131 and Y-90 labeled antitenascin Monoclonal Antibodies.
    Riva, P
    Franceschi, G
    Frattarelli, M
    Riva, N
    Guiducci
    Cremonini, AM
    Giuliani, G
    Casi, M
    Gentile, R
    RADIOACTIVE ISOTOPES IN CLINICAL MEDICINE AND RESEARCH XXIII, 1999, : 59 - 63
  • [8] Thyroid radiation doses during radioimmunotherapy of CEA-expressing tumours with I-131-labelled monoclonal antibodies
    Behr, TM
    Juweid, ME
    Sharkey, RM
    Dunn, RM
    Ying, Z
    Becker, WS
    Siegel, JA
    Goldenberg, DM
    NUCLEAR MEDICINE COMMUNICATIONS, 1996, 17 (09) : 767 - 780
  • [9] RADIOIMMUNOTHERAPY OF SOLITARY LIVER METASTASES BY MEANS OF INTRATUMORAL INSTILLATION OF I-131-LABELLED MONOCLONAL-ANTIBODIES - PRELIMINARY-RESULTS OF A CLINICAL-TRIAL
    MULLERGARTNER, HW
    MONTZ, R
    KLAPDOR, R
    HIRSCHMANN, M
    REHPENNING, W
    LANGKOWSKI, J
    NUKLEARMEDIZIN, 1988, 27 (06) : 258 - 265
  • [10] BIODISTRIBUTION OF I-131-LABELLED MONOCLONAL-ANTIBODIES IN HUMAN-COLON TUMORS BY AN EXVIVO PERFUSION MODEL
    KRAAS, E
    LOHDE, E
    ABRI, O
    SCHLICKER, H
    MATZKU, S
    KALTHOFF, H
    SCHMIEGEL, W
    ARNDT, R
    INTERNATIONAL JOURNAL OF CANCER, 1988, : 77 - 82
12345